ABSTRACT
Introduction
Hepatocellular carcinoma (HCC) is the sixth most common neoplasm worldwide and the third most common cause of cancer mortality, accounting for 9.2% of all cancer deaths 1 . Overall, its incidence has been estimated at 10.8 per 100.000 person-years;
however, almost 85% of the cases occur in developing countries 2 .
In 2008, about 750.000 new HCC cases were reported worldwide, with 13 .300 HCC cases in North America and 57.900 in Europe 1 .
All these rates increased from the previous global cancer statistics 3 .
In Brazil, its clinical and epidemiological aspects widely vary amongst different regions 4 , where is considered a neoplasm of low prevalence in general 5 .
Liver transplantation (LT) represents the most promising product of modern surgery for treatment of patients suffering from chronic end-stage liver disease and remains a cornerstone in the management of patients with HCC 6 . On the other hand, recurrence of hepatocellular carcinoma after LT is common as 13.4%, which leads to an unfavorable prognosis with mortality rate about 56.3% 7 . Thus, as factors related to cancer alone are not enough to predict prognosis of patients with HCC undergoing surgical treatments 8 , to identify non-cancerous prognostic factors it may serve to improve outcomes, selecting appropriated approaches.
The aim of this study was to explore non-cancerous prognostic factors that may be related with medium-term survival among patients undergoing LT due to HCC at the University of Then, factors whose association with survival showed a p-value < 0.20 were used in a multivariate Cox's proportional-hazards model in order to identify the independent prognostic factor. We additionally adjusted this multivariate analysis for transplantation era (quartiles) and allocation criteria (chronologic vs. MELD).
Median follow-up of alive patients was 44.6 months (Q 25 =34.7-Q 75 =51.6) and all of them was followed for at least 24-month in order to determine the primary endpoint (death).
The statistical analyses were performed using the Table 1 . .
Exploring prognostic factor offers the opportunity to predict outcomes and may serve to improve the treatment for HCC patients who received ortothopic LT. By far, their main determinants of outcome have repeatedly been found to be lymphovascular invasion and poor differentiation, which reflects the biological aggressiveness of tumor 2, [13] [14] [15] [16] [17] . Similarly, pretransplantation treatments have been also described as prognostic factors of survival for this malignancy 15, 18 . However, there is a lack of evidence if non-cancerous factors, beyond those described above, influence survival outcomes of HCC patient after LT.
The prognosis for HCC patients is usually very poor, unless patients can be identified at an early stage with preserved liver functions 19, 20 . On the other hand, based in the MELD score, we did not confirm the critical role of cirrhosis severity for post-LT survival of HCC patients. This finding probably occurred because a large proportion of these patients do not have severe liver disease at the time of LT [21] [22] [23] , when the effect of their hepatic dysfunction may not be clinically relevant to translate into a survival outcome 24, 25 . Accordingly, because HCC patients exhibit better liver function than non-HCC at the time of LT 18, 21, 22, 25, 26 , this preserved liver function may also attenuate the negative impact of transfusion-related immunomodulation (TRIM syndrome) 27 on survival of patients with HCC and may explain our divergent results previously published, where red blood transfusion was found as a independent prognostic factor of survival into a sample including HCC and non-HCC patients 21 .
If survival of HCC patients is influenced by the etiology of the liver disease or patient sex remains controversial. According to our data, concurrent hepatitis C virus diagnosis and patient sex, do not appear significantly influencing survival of HCC patients after LT, in agreement with some previous data 23, 29 . On the contrary, female patients and some liver disease may provide better prognosis to patients with HCC, but this is possibly more because of higher compliance with surveillance than to real biological differences 28, 29 . Moreover, some of others donor-, In randomized Brazilian reports, the piggy-back approach was related to higher rate of pulmonary infiltrates 38 , but not to bacterial translocation 39 or stimuli for the production of inflammatory molecules 40 , when compared to the conventional method. However, until publication of this study, there were no trials comparing piggy-back with conventional method without veno-venous bypass 37 . In our Department, our learning curve evolved initially with this last, which is performed with recognized swiftness and has been preferred whenever technical difficulty arose during performance of the hepatectomy 41 . Thus, also because same regional socio-economic limitations (i.e.: IDH=0.7), we have accumulated considerable experience with the management of marginal grafts 42, 43 and use of conventional technique without veno-venous bypass 21, 41, 44 . On the other hand, the piggy-back approach has been increasingly used at our Department because lower surgical and warm ischemia times, red blood cells and plasma transfusions, as well as lower 30-day mortality and better 1-year cumulative survival 41 .
The piggy-back technique has been suggested to be avoided in patients with HCC because an theoretical increased risk of a positive vena cava margin and the potential for metastatic spread of tumor in the native vena cava or through the hepatic veins, as well as because an increased operative manipulation of the diseased organ in this approach 45 45 .
In line with recent recommendations and practice in observational research 47 , all analysis of this study considered a p-value of 0.01 to denote statistical significance. Furthermore, instead of categorising continuous variables, we prefer to keep them continuous in order to minimize some loss in the statistical power of our analysis and the occurrence of residual confounding factors 48, 49 . Similarly, because a significant increase in the number of patients transplanted to treat HCC in our Department as result of MELD allocation policy and because better survival outcomes observed in the most recent periods of our transplantation activities, probably due to governmental efforts to encourage organ transplantation 21 ; we also adjusted our multivariate analysis for the allocation criteria (chronologic vs. MELD) and transplantation eras (quartiles). In this approach, separate regression models were first fit to each group and the log-likelihoods for those models were summed up. This log-likelihood was then compared to that of the overall model (collapsed across groups).
We also point that analysis of additional donor-related variables may provide additional information, especially because a large proportion of extended-criteria donors were used at our Department 21, 34, 42, 43 . However, despite our relative small sample size, the main scientific merit of this report was to add some evidence to determine if the surgical approach influence survival outcomes of HCC patients after LT. Our data suggests further studies are necessary to determine whether piggyback hepatovenous anastomosis should be preferred for patients candidate to LT because HCC.
Conclusion
The piggyback hepato-venous reconstruction technique was related to improved medium-term survival of hepatocellular carcinoma patients after liver transplantation in this northeast
Brazilian sample.
